메뉴 건너뛰기




Volumn 25, Issue 4, 2011, Pages 773-788

Polyclonal Immunoglobulins and Hyperimmune Globulins in Prevention and Management of Infectious Diseases

Author keywords

Cytomegalovirus; Immunoglobulin; IVIG; Sepsis; Toxic shock; Viral hepatitis

Indexed keywords

ANTIBIOTIC AGENT; ANTITOXIN; BOTULINUM TOXIN; CYTOMEGALOVIRUS ANTIBODY; DIPHTHERIA ANTIBODY; GANCICLOVIR; HEPATITIS A VACCINE; HEPATITIS B ANTIBODY; HERPES ZOSTER IMMUNOGLOBULIN; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LAMIVUDINE; MONOCLONAL ANTIBODY; PLACEBO; RABIES IMMUNOGLOBULIN; RIBAVIRIN; TETANUS ANTIBODY; TETANUS TOXOID; VALGANCICLOVIR;

EID: 80455177268     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2011.07.005     Document Type: Review
Times cited : (34)

References (89)
  • 1
    • 53649102120 scopus 로고    scopus 로고
    • History of immunoglobulin replacement
    • viii
    • Eibl M.M. History of immunoglobulin replacement. Immunol Allergy Clin North Am 2008, 28(4):737-764. viii.
    • (2008) Immunol Allergy Clin North Am , vol.28 , Issue.4 , pp. 737-764
    • Eibl, M.M.1
  • 2
    • 0036228218 scopus 로고    scopus 로고
    • In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations-a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases
    • Krause I., Wu R., Sherer Y., et al. In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations-a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases. Transfus Med 2002, 12(2):133-139.
    • (2002) Transfus Med , vol.12 , Issue.2 , pp. 133-139
    • Krause, I.1    Wu, R.2    Sherer, Y.3
  • 3
    • 72149111128 scopus 로고    scopus 로고
    • Intravenous immunoglobulins-understanding properties and mechanisms
    • Durandy A., Kaveri S.V., Kuijpers T.W., et al. Intravenous immunoglobulins-understanding properties and mechanisms. Clin Exp Immunol 2009, 158(Suppl 1):2-13.
    • (2009) Clin Exp Immunol , vol.158 , Issue.SUPPL. 1 , pp. 2-13
    • Durandy, A.1    Kaveri, S.V.2    Kuijpers, T.W.3
  • 4
    • 54749099644 scopus 로고    scopus 로고
    • Unlabeled uses of intravenous immune globulin
    • Leong H., Stachnik J., Bonk M.E., et al. Unlabeled uses of intravenous immune globulin. Am J Health Syst Pharm 2008, 65(19):1815-1824.
    • (2008) Am J Health Syst Pharm , vol.65 , Issue.19 , pp. 1815-1824
    • Leong, H.1    Stachnik, J.2    Bonk, M.E.3
  • 5
    • 33645341439 scopus 로고    scopus 로고
    • Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology
    • Orange J.S., Hossny E.M., Weiler C.R., et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2006, 117(Suppl 4):S525-S553.
    • (2006) J Allergy Clin Immunol , vol.117 , Issue.SUPPL. 4
    • Orange, J.S.1    Hossny, E.M.2    Weiler, C.R.3
  • 6
    • 33646249914 scopus 로고    scopus 로고
    • Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature
    • Darabi K., Abdel-Wahab O., Dzik W.H. Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature. Transfusion 2006, 46(5):741-753.
    • (2006) Transfusion , vol.46 , Issue.5 , pp. 741-753
    • Darabi, K.1    Abdel-Wahab, O.2    Dzik, W.H.3
  • 7
    • 33748057490 scopus 로고    scopus 로고
    • Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation
    • Sriskandan S., Ferguson M., Elliot V., et al. Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation. J Antimicrob Chemother 2006, 58(1):117-124.
    • (2006) J Antimicrob Chemother , vol.58 , Issue.1 , pp. 117-124
    • Sriskandan, S.1    Ferguson, M.2    Elliot, V.3
  • 8
    • 0035004294 scopus 로고    scopus 로고
    • Pathophysiology of septic shock and multiple organ dysfunction syndrome and various therapeutic approaches with special emphasis on immunoglobulins
    • Werdan K. Pathophysiology of septic shock and multiple organ dysfunction syndrome and various therapeutic approaches with special emphasis on immunoglobulins. Ther Apher 2001, 5(2):115-122.
    • (2001) Ther Apher , vol.5 , Issue.2 , pp. 115-122
    • Werdan, K.1
  • 9
    • 36448938357 scopus 로고    scopus 로고
    • Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock
    • Kreymann K.G., de Heer G., Nierhaus A., et al. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 2007, 35(12):2677-2685.
    • (2007) Crit Care Med , vol.35 , Issue.12 , pp. 2677-2685
    • Kreymann, K.G.1    de Heer, G.2    Nierhaus, A.3
  • 10
    • 33847009520 scopus 로고    scopus 로고
    • Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis
    • Turgeon A.F., Hutton B., Fergusson D.A., et al. Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med 2007, 146(3):193-203.
    • (2007) Ann Intern Med , vol.146 , Issue.3 , pp. 193-203
    • Turgeon, A.F.1    Hutton, B.2    Fergusson, D.A.3
  • 11
    • 36448996190 scopus 로고    scopus 로고
    • Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis
    • Laupland K.B., Kirkpatrick A.W., Delaney A. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med 2007, 35(12):2686-2692.
    • (2007) Crit Care Med , vol.35 , Issue.12 , pp. 2686-2692
    • Laupland, K.B.1    Kirkpatrick, A.W.2    Delaney, A.3
  • 12
  • 13
    • 16244362082 scopus 로고    scopus 로고
    • Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery
    • Rodriguez A., Rello J., Neira J., et al. Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery. Shock 2005, 23(4):298-304.
    • (2005) Shock , vol.23 , Issue.4 , pp. 298-304
    • Rodriguez, A.1    Rello, J.2    Neira, J.3
  • 14
    • 0035048611 scopus 로고    scopus 로고
    • Treatment of sepsis in cardiac surgery: role of immunoglobulins
    • Sablotzki A., Muhling J., Dehne M.G., et al. Treatment of sepsis in cardiac surgery: role of immunoglobulins. Perfusion 2001, 16(2):113-120.
    • (2001) Perfusion , vol.16 , Issue.2 , pp. 113-120
    • Sablotzki, A.1    Muhling, J.2    Dehne, M.G.3
  • 15
    • 0028128048 scopus 로고
    • Early sepsis treatment with immunoglobulins after cardiac surgery in score-identified high-risk patients
    • Pilz G., Kreuzer E., Kaab S., et al. Early sepsis treatment with immunoglobulins after cardiac surgery in score-identified high-risk patients. Chest 1994, 105(1):76-82.
    • (1994) Chest , vol.105 , Issue.1 , pp. 76-82
    • Pilz, G.1    Kreuzer, E.2    Kaab, S.3
  • 16
    • 0026647438 scopus 로고
    • Intravenous immunoglobulin therapy for toxic shock syndrome
    • Barry W., Hudgins L., Donta S.T., et al. Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA 1992, 267(24):3315-3316.
    • (1992) JAMA , vol.267 , Issue.24 , pp. 3315-3316
    • Barry, W.1    Hudgins, L.2    Donta, S.T.3
  • 17
    • 0032924155 scopus 로고    scopus 로고
    • Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. The Canadian Streptococcal Study Group
    • Kaul R., McGeer A., Norrby-Teglund A., et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 1999, 28(4):800-807.
    • (1999) Clin Infect Dis , vol.28 , Issue.4 , pp. 800-807
    • Kaul, R.1    McGeer, A.2    Norrby-Teglund, A.3
  • 18
    • 0032014832 scopus 로고    scopus 로고
    • Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome
    • Stevens D.L. Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome. Clin Infect Dis 1998, 26(3):639-641.
    • (1998) Clin Infect Dis , vol.26 , Issue.3 , pp. 639-641
    • Stevens, D.L.1
  • 19
    • 0041402681 scopus 로고    scopus 로고
    • Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial
    • Darenberg J., Ihendyane N., Sjolin J., et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003, 37(3):333-340.
    • (2003) Clin Infect Dis , vol.37 , Issue.3 , pp. 333-340
    • Darenberg, J.1    Ihendyane, N.2    Sjolin, J.3
  • 20
    • 72849139516 scopus 로고    scopus 로고
    • Intravenous immunoglobulin in children with streptococcal toxic shock syndrome
    • Shah S.S., Hall M., Srivastava R., et al. Intravenous immunoglobulin in children with streptococcal toxic shock syndrome. Clin Infect Dis 2009, 49(9):1369-1376.
    • (2009) Clin Infect Dis , vol.49 , Issue.9 , pp. 1369-1376
    • Shah, S.S.1    Hall, M.2    Srivastava, R.3
  • 21
    • 1642319406 scopus 로고    scopus 로고
    • Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome
    • Darenberg J., Soderquist B., Normark B.H., et al. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome. Clin Infect Dis 2004, 38(6):836-842.
    • (2004) Clin Infect Dis , vol.38 , Issue.6 , pp. 836-842
    • Darenberg, J.1    Soderquist, B.2    Normark, B.H.3
  • 22
    • 2442464696 scopus 로고    scopus 로고
    • Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001
    • Archibald L.K., Banerjee S.N., Jarvis W.R. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 2004, 189(9):1585-1589.
    • (2004) J Infect Dis , vol.189 , Issue.9 , pp. 1585-1589
    • Archibald, L.K.1    Banerjee, S.N.2    Jarvis, W.R.3
  • 23
    • 4344559215 scopus 로고    scopus 로고
    • Factors associated with failure of metronidazole in Clostridium difficile-associated disease
    • Fernandez A., Anand G., Friedenberg F. Factors associated with failure of metronidazole in Clostridium difficile-associated disease. J Clin Gastroenterol 2004, 38(5):414-418.
    • (2004) J Clin Gastroenterol , vol.38 , Issue.5 , pp. 414-418
    • Fernandez, A.1    Anand, G.2    Friedenberg, F.3
  • 24
    • 0036467063 scopus 로고    scopus 로고
    • Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile
    • Kyne L., Hamel M.B., Polavaram R., et al. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002, 34(3):346-353.
    • (2002) Clin Infect Dis , vol.34 , Issue.3 , pp. 346-353
    • Kyne, L.1    Hamel, M.B.2    Polavaram, R.3
  • 25
    • 0023503051 scopus 로고
    • Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters
    • Kim P.H., Iaconis J.P., Rolfe R.D. Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters. Infect Immun 1987, 55(12):2984-2992.
    • (1987) Infect Immun , vol.55 , Issue.12 , pp. 2984-2992
    • Kim, P.H.1    Iaconis, J.P.2    Rolfe, R.D.3
  • 26
    • 0025804091 scopus 로고
    • Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate
    • Lyerly D.M., Bostwick E.F., Binion S.B., et al. Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infect Immun 1991, 59(6):2215-2218.
    • (1991) Infect Immun , vol.59 , Issue.6 , pp. 2215-2218
    • Lyerly, D.M.1    Bostwick, E.F.2    Binion, S.B.3
  • 27
    • 78649807947 scopus 로고    scopus 로고
    • Management of Clostridium difficile infection: thinking inside and outside the box
    • Gerding D.N., Johnson S. Management of Clostridium difficile infection: thinking inside and outside the box. Clin Infect Dis 2010, 51(11):1306-1313.
    • (2010) Clin Infect Dis , vol.51 , Issue.11 , pp. 1306-1313
    • Gerding, D.N.1    Johnson, S.2
  • 28
    • 0034628426 scopus 로고    scopus 로고
    • Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A
    • Kyne L., Warny M., Qamar A., et al. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000, 342(6):390-397.
    • (2000) N Engl J Med , vol.342 , Issue.6 , pp. 390-397
    • Kyne, L.1    Warny, M.2    Qamar, A.3
  • 29
    • 79151476267 scopus 로고    scopus 로고
    • Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review
    • Abougergi M.S., Kwon J.H. Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review. Dig Dis Sci 2011, 56(1):19-26.
    • (2011) Dig Dis Sci , vol.56 , Issue.1 , pp. 19-26
    • Abougergi, M.S.1    Kwon, J.H.2
  • 30
    • 70349491503 scopus 로고    scopus 로고
    • The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review
    • O'Horo J., Safdar N. The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review. Int J Infect Dis 2009, 13(6):663-667.
    • (2009) Int J Infect Dis , vol.13 , Issue.6 , pp. 663-667
    • O'Horo, J.1    Safdar, N.2
  • 31
    • 0030763467 scopus 로고    scopus 로고
    • Intravenous immunoglobulin therapy for severe Clostridium difficile colitis
    • Salcedo J., Keates S., Pothoulakis C., et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut 1997, 41(3):366-370.
    • (1997) Gut , vol.41 , Issue.3 , pp. 366-370
    • Salcedo, J.1    Keates, S.2    Pothoulakis, C.3
  • 32
    • 74849098405 scopus 로고    scopus 로고
    • Treatment with monoclonal antibodies against Clostridium difficile toxins
    • Lowy I., Molrine D.C., Leav B.A., et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 2010, 362(3):197-205.
    • (2010) N Engl J Med , vol.362 , Issue.3 , pp. 197-205
    • Lowy, I.1    Molrine, D.C.2    Leav, B.A.3
  • 33
    • 84925549068 scopus 로고    scopus 로고
    • Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel
    • Kretsinger K., Broder K.R., Cortese M.M., et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 2006, 55(RR-17):1-37.
    • (2006) MMWR Recomm Rep , vol.55 , Issue.17 , pp. 1-37
    • Kretsinger, K.1    Broder, K.R.2    Cortese, M.M.3
  • 34
    • 79954508220 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention (CDC) Tetanus surveillance-United States, 2001-2008
    • Centers for Disease Control and Prevention (CDC) Tetanus surveillance-United States, 2001-2008. MMWR Morb Mortal Wkly Rep 2011, 60(12):365-369.
    • (2011) MMWR Morb Mortal Wkly Rep , vol.60 , Issue.12 , pp. 365-369
  • 35
    • 79952235043 scopus 로고    scopus 로고
    • Narrative review: tetanus-a health threat after natural disasters in developing countries
    • Afshar M., Raju M., Ansell D., et al. Narrative review: tetanus-a health threat after natural disasters in developing countries. Ann Intern Med 2011, 154(5):329-335.
    • (2011) Ann Intern Med , vol.154 , Issue.5 , pp. 329-335
    • Afshar, M.1    Raju, M.2    Ansell, D.3
  • 36
    • 0033793926 scopus 로고    scopus 로고
    • Passive immunity in prevention and treatment of infectious diseases
    • Keller M.A., Stiehm E.R. Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev 2000, 13(4):602-614.
    • (2000) Clin Microbiol Rev , vol.13 , Issue.4 , pp. 602-614
    • Keller, M.A.1    Stiehm, E.R.2
  • 37
    • 77949581390 scopus 로고    scopus 로고
    • Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E
    • Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E. MMWR Morb Mortal Wkly Rep 2010, 59(10):299.
    • (2010) MMWR Morb Mortal Wkly Rep , vol.59 , Issue.10 , pp. 299
  • 38
    • 80455171781 scopus 로고    scopus 로고
    • Organization WH. WHO vaccine-preventable diseases monitoring system: 2010 global summary, Geneva (Switzerland): World Health Organization;
    • Organization WH. WHO vaccine-preventable diseases monitoring system: 2010 global summary, vol. 2. Geneva (Switzerland): World Health Organization; 2010. p. R-234.
    • (2010) , vol.2
  • 40
    • 34547648810 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention (CDC) Availability of diphtheria antitoxin through an investigational new drug protocol
    • Centers for Disease Control and Prevention (CDC) Availability of diphtheria antitoxin through an investigational new drug protocol. MMWR Morb Mortal Wkly Rep 1997, 46(17):380.
    • (1997) MMWR Morb Mortal Wkly Rep , vol.46 , Issue.17 , pp. 380
  • 41
    • 0023266643 scopus 로고
    • Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients
    • Snydman D.R., Werner B.G., Heinze-Lacey B., et al. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med 1987, 317(17):1049-1054.
    • (1987) N Engl J Med , vol.317 , Issue.17 , pp. 1049-1054
    • Snydman, D.R.1    Werner, B.G.2    Heinze-Lacey, B.3
  • 42
    • 0027483992 scopus 로고
    • Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial
    • Snydman D.R., Werner B.G., Dougherty N.N., et al. Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1993, 119(10):984-991.
    • (1993) Ann Intern Med , vol.119 , Issue.10 , pp. 984-991
    • Snydman, D.R.1    Werner, B.G.2    Dougherty, N.N.3
  • 43
    • 36249015226 scopus 로고    scopus 로고
    • Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients
    • CD005129
    • Hodson E.M., Jones C.A., Strippoli G.F., et al. Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev 2007, 2. CD005129.
    • (2007) Cochrane Database Syst Rev , vol.2
    • Hodson, E.M.1    Jones, C.A.2    Strippoli, G.F.3
  • 44
    • 72949103510 scopus 로고    scopus 로고
    • Cytomegalovirus in solid organ transplant recipients
    • Humar A., Snydman D. Cytomegalovirus in solid organ transplant recipients. Am J Transplant 2009, 9(Suppl 4):S78-S86.
    • (2009) Am J Transplant , vol.9 , Issue.SUPPL. 4
    • Humar, A.1    Snydman, D.2
  • 45
    • 77957280871 scopus 로고    scopus 로고
    • An international survey of cytomegalovirus management practices in lung transplantation
    • Zuk D.M., Humar A., Weinkauf J.G., et al. An international survey of cytomegalovirus management practices in lung transplantation. Transplantation 2010, 90(6):672-676.
    • (2010) Transplantation , vol.90 , Issue.6 , pp. 672-676
    • Zuk, D.M.1    Humar, A.2    Weinkauf, J.G.3
  • 46
    • 34548703848 scopus 로고    scopus 로고
    • The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections
    • Carbone J., Sarmiento E., Palomo J., et al. The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections. Transplant Proc 2007, 39(7):2385-2388.
    • (2007) Transplant Proc , vol.39 , Issue.7 , pp. 2385-2388
    • Carbone, J.1    Sarmiento, E.2    Palomo, J.3
  • 47
    • 77950926374 scopus 로고    scopus 로고
    • International consensus guidelines on the management of cytomegalovirus in solid organ transplantation
    • Kotton C.N., Kumar D., Caliendo A.M., et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010, 89(7):779-795.
    • (2010) Transplantation , vol.89 , Issue.7 , pp. 779-795
    • Kotton, C.N.1    Kumar, D.2    Caliendo, A.M.3
  • 48
    • 0022575268 scopus 로고
    • Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation
    • Bowden R.A., Sayers M., Flournoy N., et al. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 1986, 314(16):1006-1010.
    • (1986) N Engl J Med , vol.314 , Issue.16 , pp. 1006-1010
    • Bowden, R.A.1    Sayers, M.2    Flournoy, N.3
  • 49
    • 0021281394 scopus 로고
    • Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin. Randomized trial in bone marrow transplant recipients
    • Condie R.M., O'Reilly R.J. Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin. Randomized trial in bone marrow transplant recipients. Am J Med 1984, 76(3A):134-141.
    • (1984) Am J Med , vol.76 , Issue.3 , pp. 134-141
    • Condie, R.M.1    O'Reilly, R.J.2
  • 50
    • 59949103959 scopus 로고    scopus 로고
    • Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis
    • Raanani P., Gafter-Gvili A., Paul M., et al. Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis. J Clin Oncol 2009, 27(5):770-781.
    • (2009) J Clin Oncol , vol.27 , Issue.5 , pp. 770-781
    • Raanani, P.1    Gafter-Gvili, A.2    Paul, M.3
  • 51
    • 0023144913 scopus 로고
    • Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation
    • Winston D.J., Ho W.G., Lin C.H., et al. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med 1987, 106(1):12-18.
    • (1987) Ann Intern Med , vol.106 , Issue.1 , pp. 12-18
    • Winston, D.J.1    Ho, W.G.2    Lin, C.H.3
  • 52
    • 0038819950 scopus 로고    scopus 로고
    • Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial
    • Cordonnier C., Chevret S., Legrand M., et al. Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial. Ann Intern Med 2003, 139(1):8-18.
    • (2003) Ann Intern Med , vol.139 , Issue.1 , pp. 8-18
    • Cordonnier, C.1    Chevret, S.2    Legrand, M.3
  • 53
    • 0024514532 scopus 로고
    • Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir
    • Verdonck L.F., de Gast G.C., Dekker A.W., et al. Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir. Bone Marrow Transplant 1989, 4(2):187-189.
    • (1989) Bone Marrow Transplant , vol.4 , Issue.2 , pp. 187-189
    • Verdonck, L.F.1    de Gast, G.C.2    Dekker, A.W.3
  • 54
    • 0024232608 scopus 로고
    • Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants
    • Reed E.C., Bowden R.A., Dandliker P.S., et al. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med 1988, 109(10):783-788.
    • (1988) Ann Intern Med , vol.109 , Issue.10 , pp. 783-788
    • Reed, E.C.1    Bowden, R.A.2    Dandliker, P.S.3
  • 55
    • 77952946091 scopus 로고    scopus 로고
    • Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients
    • Alexander B.T., Hladnik L.M., Augustin K.M., et al. Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients. Pharmacotherapy 2010, 30(6):554-561.
    • (2010) Pharmacotherapy , vol.30 , Issue.6 , pp. 554-561
    • Alexander, B.T.1    Hladnik, L.M.2    Augustin, K.M.3
  • 56
    • 0024230867 scopus 로고
    • Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin
    • Emanuel D., Cunningham I., Jules-Elysee K., et al. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med 1988, 109(10):777-782.
    • (1988) Ann Intern Med , vol.109 , Issue.10 , pp. 777-782
    • Emanuel, D.1    Cunningham, I.2    Jules-Elysee, K.3
  • 57
    • 0001484781 scopus 로고
    • The etiology of infectious hepatitis
    • [discussion: 676-9]
    • Havens W.P. The etiology of infectious hepatitis. J Am Med Assoc 1947, 134(8):653-655. [discussion: 676-9].
    • (1947) J Am Med Assoc , vol.134 , Issue.8 , pp. 653-655
    • Havens, W.P.1
  • 58
    • 77049221672 scopus 로고
    • Use of gamma globulin for control of infectious hepatitis in an institution for the mentally retarded
    • Ashley A. Use of gamma globulin for control of infectious hepatitis in an institution for the mentally retarded. N Engl J Med 1955, 252(3):88-91.
    • (1955) N Engl J Med , vol.252 , Issue.3 , pp. 88-91
    • Ashley, A.1
  • 59
    • 35348976213 scopus 로고    scopus 로고
    • Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC) Update: prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC) Update: prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2007, 56(41):1080-1084.
    • (2007) MMWR Morb Mortal Wkly Rep , vol.56 , Issue.41 , pp. 1080-1084
  • 60
    • 33646715581 scopus 로고    scopus 로고
    • Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • Fiore A.E., Wasley A., Bell B.P. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006, 55(RR-7):1-23.
    • (2006) MMWR Recomm Rep , vol.55 , Issue.7 , pp. 1-23
    • Fiore, A.E.1    Wasley, A.2    Bell, B.P.3
  • 62
    • 35548959176 scopus 로고    scopus 로고
    • Hepatitis A vaccine versus immune globulin for postexposure prophylaxis
    • Victor J.C., Monto A.S., Surdina T.Y., et al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 2007, 357(17):1685-1694.
    • (2007) N Engl J Med , vol.357 , Issue.17 , pp. 1685-1694
    • Victor, J.C.1    Monto, A.S.2    Surdina, T.Y.3
  • 63
    • 39049191182 scopus 로고    scopus 로고
    • A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults
    • [quiz: CE31-4]
    • Mast E.E., Weinbaum C.M., Fiore A.E., et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006, 55(RR-16):1-33. [quiz: CE31-4].
    • (2006) MMWR Recomm Rep , vol.55 , Issue.16 , pp. 1-33
    • Mast, E.E.1    Weinbaum, C.M.2    Fiore, A.E.3
  • 64
    • 0024341965 scopus 로고
    • Combined hepatitis B immune globulin and vaccine for postexposure prophylaxis of accidental hepatitis B virus infection in hemodialysis staff members: comparison with immune globulin without vaccine in historical controls
    • Mitsui T., Iwano K., Suzuki S., et al. Combined hepatitis B immune globulin and vaccine for postexposure prophylaxis of accidental hepatitis B virus infection in hemodialysis staff members: comparison with immune globulin without vaccine in historical controls. Hepatology 1989, 10(3):324-327.
    • (1989) Hepatology , vol.10 , Issue.3 , pp. 324-327
    • Mitsui, T.1    Iwano, K.2    Suzuki, S.3
  • 65
    • 0021908344 scopus 로고
    • Post-exposure active immunoprophylaxis of spouses of acute viral hepatitis B patients
    • Roumeliotou-Karayannis A., Papaevangelou G., Tassopoulos N., et al. Post-exposure active immunoprophylaxis of spouses of acute viral hepatitis B patients. Vaccine 1985, 3(1):31-34.
    • (1985) Vaccine , vol.3 , Issue.1 , pp. 31-34
    • Roumeliotou-Karayannis, A.1    Papaevangelou, G.2    Tassopoulos, N.3
  • 66
    • 0018177459 scopus 로고
    • Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial
    • Grady G.F., Lee V.A., Prince A.M., et al. Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis 1978, 138(5):625-638.
    • (1978) J Infect Dis , vol.138 , Issue.5 , pp. 625-638
    • Grady, G.F.1    Lee, V.A.2    Prince, A.M.3
  • 67
    • 0016784820 scopus 로고
    • Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis
    • Redeker A.G., Mosley J.W., Gocke D.J., et al. Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis. N Engl J Med 1975, 293(21):1055-1059.
    • (1975) N Engl J Med , vol.293 , Issue.21 , pp. 1055-1059
    • Redeker, A.G.1    Mosley, J.W.2    Gocke, D.J.3
  • 68
    • 0017878739 scopus 로고
    • Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study
    • Seeff L.B., Wright E.C., Zimmerman H.J., et al. Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. Ann Intern Med 1978, 88(3):285-293.
    • (1978) Ann Intern Med , vol.88 , Issue.3 , pp. 285-293
    • Seeff, L.B.1    Wright, E.C.2    Zimmerman, H.J.3
  • 69
    • 77955481931 scopus 로고    scopus 로고
    • Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation
    • CD006005
    • Katz L.H., Tur-Kaspa R., Guy D.G., et al. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation. Cochrane Database Syst Rev 2010, 7. CD006005.
    • (2010) Cochrane Database Syst Rev , vol.7
    • Katz, L.H.1    Tur-Kaspa, R.2    Guy, D.G.3
  • 70
    • 77951737280 scopus 로고    scopus 로고
    • Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: a systematic review
    • Chen J., Yi L., Jia J.D., et al. Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: a systematic review. J Gastroenterol Hepatol 2010, 25(5):872-879.
    • (2010) J Gastroenterol Hepatol , vol.25 , Issue.5 , pp. 872-879
    • Chen, J.1    Yi, L.2    Jia, J.D.3
  • 71
    • 0018162641 scopus 로고
    • Antibody to varicella-zoster virus after passive immunization against chickenpox
    • Gershon A.A., Piomelli S., Karpatkin M., et al. Antibody to varicella-zoster virus after passive immunization against chickenpox. J Clin Microbiol 1978, 8(6):733-735.
    • (1978) J Clin Microbiol , vol.8 , Issue.6 , pp. 733-735
    • Gershon, A.A.1    Piomelli, S.2    Karpatkin, M.3
  • 72
    • 0021085162 scopus 로고
    • Zoster immunoglobulin in varicella prophylaxis. A study among high-risk patients
    • Hanngren K., Falksveden L., Grandien M., et al. Zoster immunoglobulin in varicella prophylaxis. A study among high-risk patients. Scand J Infect Dis 1983, 15(4):327-334.
    • (1983) Scand J Infect Dis , vol.15 , Issue.4 , pp. 327-334
    • Hanngren, K.1    Falksveden, L.2    Grandien, M.3
  • 73
    • 0030581083 scopus 로고    scopus 로고
    • Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention
    • Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep 1996, 45(RR-11):1-36.
    • (1996) MMWR Recomm Rep , vol.45 , Issue.11 , pp. 1-36
  • 74
    • 34250688647 scopus 로고    scopus 로고
    • Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • Marin M., Guris D., Chaves S.S., et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56(RR-4):1-40.
    • (2007) MMWR Recomm Rep , vol.56 , Issue.4 , pp. 1-40
    • Marin, M.1    Guris, D.2    Chaves, S.S.3
  • 75
    • 0021279137 scopus 로고
    • Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin
    • Paryani S.G., Arvin A.M., Koropchak C.M., et al. Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin. Am J Med 1984, 76(3A):124-127.
    • (1984) Am J Med , vol.76 , Issue.3 , pp. 124-127
    • Paryani, S.G.1    Arvin, A.M.2    Koropchak, C.M.3
  • 76
    • 0008048635 scopus 로고
    • Laboratory data supporting the clinical trial of anti-rabies serum in persons bitten by a rabid wolf
    • Habel K., Koprowski H. Laboratory data supporting the clinical trial of anti-rabies serum in persons bitten by a rabid wolf. Bull World Health Organ 1955, 13(5):773-779.
    • (1955) Bull World Health Organ , vol.13 , Issue.5 , pp. 773-779
    • Habel, K.1    Koprowski, H.2
  • 77
    • 0024119409 scopus 로고
    • Use of serum and vaccine in combination for prophylaxis following exposure to rabies
    • Lin F.T., Chen S.B., Wang Y.Z., et al. Use of serum and vaccine in combination for prophylaxis following exposure to rabies. Rev Infect Dis 1988, 10(Suppl 4):S766-S770.
    • (1988) Rev Infect Dis , vol.10 , Issue.SUPPL. 4
    • Lin, F.T.1    Chen, S.B.2    Wang, Y.Z.3
  • 78
    • 0029990164 scopus 로고    scopus 로고
    • What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously?
    • Khawplod P., Wilde H., Chomchey P., et al. What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously?. Vaccine 1996, 14(5):389-391.
    • (1996) Vaccine , vol.14 , Issue.5 , pp. 389-391
    • Khawplod, P.1    Wilde, H.2    Chomchey, P.3
  • 79
    • 44349123571 scopus 로고    scopus 로고
    • Human rabies prevention-United States, 2008: recommendations of the Advisory Committee on Immunization Practices
    • Manning S.E., Rupprecht C.E., Fishbein D., et al. Human rabies prevention-United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2008, 57(RR-3):1-28.
    • (2008) MMWR Recomm Rep , vol.57 , Issue.3 , pp. 1-28
    • Manning, S.E.1    Rupprecht, C.E.2    Fishbein, D.3
  • 80
    • 0026590118 scopus 로고
    • An outbreak of respiratory syncytial virus in a bone marrow transplant center
    • Harrington R.D., Hooton T.M., Hackman R.C., et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 1992, 165(6):987-993.
    • (1992) J Infect Dis , vol.165 , Issue.6 , pp. 987-993
    • Harrington, R.D.1    Hooton, T.M.2    Hackman, R.C.3
  • 81
    • 0029154365 scopus 로고
    • Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients
    • Whimbey E., Champlin R.E., Englund J.A., et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant 1995, 16(3):393-399.
    • (1995) Bone Marrow Transplant , vol.16 , Issue.3 , pp. 393-399
    • Whimbey, E.1    Champlin, R.E.2    Englund, J.A.3
  • 82
    • 0034105067 scopus 로고    scopus 로고
    • Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin
    • Ghosh S., Champlin R.E., Englund J., et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant 2000, 25(7):751-755.
    • (2000) Bone Marrow Transplant , vol.25 , Issue.7 , pp. 751-755
    • Ghosh, S.1    Champlin, R.E.2    Englund, J.3
  • 83
    • 0032886187 scopus 로고    scopus 로고
    • Adverse effects of intravenous immunoglobulin therapy
    • Nydegger U.E., Sturzenegger M. Adverse effects of intravenous immunoglobulin therapy. Drug Saf 1999, 21(3):171-185.
    • (1999) Drug Saf , vol.21 , Issue.3 , pp. 171-185
    • Nydegger, U.E.1    Sturzenegger, M.2
  • 84
    • 0025840563 scopus 로고
    • Enteral immunoglobulins for treatment of protracted rotaviral diarrhea
    • Guarino A., Guandalini S., Albano F., et al. Enteral immunoglobulins for treatment of protracted rotaviral diarrhea. Pediatr Infect Dis J 1991, 10(8):612-614.
    • (1991) Pediatr Infect Dis J , vol.10 , Issue.8 , pp. 612-614
    • Guarino, A.1    Guandalini, S.2    Albano, F.3
  • 85
    • 1642543876 scopus 로고
    • Oral immunoglobulin treatment in Campylobacter jejuni enteritis
    • Hammarstrom V., Smith C.I., Hammarstrom L. Oral immunoglobulin treatment in Campylobacter jejuni enteritis. Lancet 1993, 341(8851):1036.
    • (1993) Lancet , vol.341 , Issue.8851 , pp. 1036
    • Hammarstrom, V.1    Smith, C.I.2    Hammarstrom, L.3
  • 86
    • 0031871760 scopus 로고    scopus 로고
    • Immunoglobulin replacement treatment by rapid subcutaneous infusion
    • Gaspar J., Gerritsen B., Jones A. Immunoglobulin replacement treatment by rapid subcutaneous infusion. Arch Dis Child 1998, 79(1):48-51.
    • (1998) Arch Dis Child , vol.79 , Issue.1 , pp. 48-51
    • Gaspar, J.1    Gerritsen, B.2    Jones, A.3
  • 87
    • 77950646691 scopus 로고    scopus 로고
    • Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load
    • Dennert R., Velthuis S., Schalla S., et al. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load. Antivir Ther 2010, 15(2):193-201.
    • (2010) Antivir Ther , vol.15 , Issue.2 , pp. 193-201
    • Dennert, R.1    Velthuis, S.2    Schalla, S.3
  • 88
    • 21244459462 scopus 로고    scopus 로고
    • Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia
    • Mouthon L., Guillevin L., Tellier Z. Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia. Autoimmun Rev 2005, 4(5):264-269.
    • (2005) Autoimmun Rev , vol.4 , Issue.5 , pp. 264-269
    • Mouthon, L.1    Guillevin, L.2    Tellier, Z.3
  • 89
    • 0023299209 scopus 로고
    • Chronic enteroviral meningoencephalitis in agammaglobulinemic patients
    • McKinney R.E., Katz S.L., Wilfert C.M. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis 1987, 9(2):334-356.
    • (1987) Rev Infect Dis , vol.9 , Issue.2 , pp. 334-356
    • McKinney, R.E.1    Katz, S.L.2    Wilfert, C.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.